复方脑肽节苷脂注射液联合阿替普酶静脉溶栓治疗急性缺血性脑卒中的安全性及疗效分析OA
Efficacy and safety analysis of compound brain peptide ganglioside injection combined with alteplase intravenous thrombolysis in the treatment of acute ischemic stroke
目的 探讨复方脑肽节苷脂注射液联合阿替普酶静脉溶栓治疗急性缺血性脑卒中的疗效.方法 选择2019年6月—2023年1月在河南省许昌中医院诊治的79例缺血性脑卒中患者,按照入院就诊顺序采用奇偶法把患者分为联合组40例与传统组39例.传统组给予阿替普酶静脉溶栓治疗,联合组给予复方脑肽节苷脂注射液联合阿替普酶静脉溶栓治疗,评价与记录联合组与传统组的疗效与安全性及治疗前、治疗14d后Fugl-Meyer评定量表(FMA)与改良版Banhel评价指数(MB…查看全部>>
Objective To explore and analysis the efficacy and safety of compound brain peptide ganglioside injection combined with alteplase intravenous thrombolysis in the treatment of acute ischemic stroke.Methods From June 2019 to January 2023,79 patients with ischemic stroke who were diagnosed and treated at Henan Xuchang Traditional Chinese Medicine Hospital were selected as the research subjects.According to the order of admission,the patients were divided into t…查看全部>>
胡一凡
河南省许昌中医院急诊科(河南许昌 461000)
复方脑肽节苷脂注射液阿替普酶静脉溶栓急性缺血性脑卒中β-内啡肽前列腺素E2
compound brain peptide ganglioside injectionalteplaseintravenous thrombolysisacute ischemic strokeβ-endorphinsprostaglandin E2
《广州医药》 2024 (3)
306-310,5
评论